Cancer

Multi-disciplinary teams (MDT) are due to take account of new lung cancer classifications from next January, Gary Culliton reports in his latest Clinical Update.

A new study in the US has revealed that prostate cancer screening by digital rectal exam and PSA testing is disappearing from primary care practice there.

The addition of a blood pressure drug may make a type of lung cancer treatment more effective, a new study has suggested.

A new study has found that enzalutamide can improve outcomes for patients with metastatic castration-resistant prostate cancer and visceral metastases compared to placebo.

GPs can have a sixth sense or “gut feeling” about a patient’s cancer diagnosis, and the older the GP the more likely they are to correctly predict cancer, new research has revealed.

Growth in the use of e-cigarettes in England has been associated with a higher rate of successful attempts to quit smoking, according to a new study in The BMJ.

Bespoke therapy is a reality for some cancer patients, and its adoption is increasing, including in lung cancer, Gary Culliton reports in his latest Clinical Update.

Researchers from the US have identified 14 genes regulating genome integrity that are consistently over-expressed in a wide variety of cancers, which they say could lead to a new biomarker for the early stages of tumour development.

Patients with cancer have heightened risks of unintentional and intentional injuries during the diagnostic process, reveal findings from a large study published by The BMJ.

While reducing the dosage or avoiding systemic anti-cancer therapy (SACT) altogether would reduce or eliminate instances of treatment-related early mortality, it would be at the cost of some patients being denied effective treatment, a new study in The Lancet Oncology has indicated.